+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Phenylketonuria Treatment Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2025

  • ID: 4802071
  • Report
  • May 2019
  • Region: Global
  • 100 pages
  • Infinium Global Research
1 of 3

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • Cambrooke T
  • Codexis, Inc.
  • Erytech Pharma
  • Synthetic Biologics, Inc.
  • MORE
The report on the global phenylketonuria treatment market provides qualitative and quantitative analysis for the period from 2017 to 2025. The report predicts the global phenylketonuria treatment market to grow with a healthy CAGR over the forecast period from 2019-2025. The study on phenylketonuria treatment market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and RoW for the period of 2017 to 2025.

The report on phenylketonuria treatment market is a comprehensive study and presentation of drivers, restraints, opportunities, demand factors, market size, forecasts, and trends in the global phenylketonuria treatment market over the period of 2017 to 2025. Moreover, the report is a collective presentation of primary and secondary research findings.

Porter's five forces model in the report provides insights into the competitive rivalry, supplier and buyer positions in the market and opportunities for the new entrants in the global phenylketonuria treatment market over the period of 2017 to 2025. Further, Growth Matrix gave in the report brings an insight into the investment areas that existing or new market players can consider.

Report Findings
1) Drivers
  • Increasing prevalence’s of phenylketonuria across the globe
  • Growth in research and development of novel drugs for phenylketonuria treatment
2) Restraints
  • High cost of treatment and strict government regulation
3) Opportunities
  • Increasing merger and acquisition, collaborations among key manufacturers are anticipated to create growth opportunities
Research Methodology

A) Primary Research
The primary research involves extensive interviews and analysis of the opinions provided by the primary respondents. The primary research starts with identifying and approaching the primary respondents, the primary respondents are approached include
1. Key Opinion Leaders associated with the author
2. Internal and External subject matter experts
3. Professionals and participants from the industry
The primary research respondents typically include
1. Executives working with leading companies in the market under review
2. Product/brand/marketing managers
3. CXO level executives
4. Regional/zonal/ country managers
5. Vice President level executives.

B) Secondary Research
Secondary research involves extensive exploring through the secondary sources of information available in both the public domain and paid sources. Each research study is based on over 500 hours of secondary research accompanied by primary research. The information obtained through the secondary sources is validated through the crosscheck on various data sources.

The secondary sources of the data typically include
1. Company reports and publications
2. Government/institutional publications
3. Trade and associations journals
4. Databases such as WTO, OECD, World Bank, and among others.
5. Websites and publications by research agencies

Segment Covered
The global phenylketonuria treatment market is segmented on the basis of product type, route of administration, and distribution channel.

The Global Phenylketonuria Treatment Market by Product Type
  • Dietary Supplement
  • Drugs
o Biopten
o Kuvan
o Others

The Global Phenylketonuria Treatment Market by Route of Administration
  • Oral
  • Parenteral
The Global Phenylketonuria Treatment Market by Distribution Channel
  • Hospital Pharmacies
  • Online Pharmacies
  • Pediatric Clinics
  • Drug Stores
Company Profiles

The companies covered in the report include
  • Erytech Pharma
  • Daiichi Sankyo Company, Limited
  • SOM Innovation Biotech, S.L.
  • Codexis, Inc.
  • Synthetic Biologics, Inc.
  • American Gene Technologies International Inc
  • Dimension Therapeutics, Inc
  • BioMarin Pharmaceutical Inc.
  • Cambrooke Therapeutics, Inc.
  • Danone
What does this report deliver?
1. Comprehensive analysis of the global as well as regional markets of the phenylketonuria treatment market.
2. Complete coverage of all the segments in the phenylketonuria treatment market to analyze the trends, developments in the global market and forecast of market size up to 2025.
3. Comprehensive analysis of the companies operating in the global phenylketonuria treatment market. The company profile includes analysis of product portfolio, revenue, SWOT analysis and latest developments of the company.
4. Growth Matrix presents an analysis of the product segments and geographies that market players should focus to invest, consolidate, expand and/or diversify.
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Cambrooke T
  • Codexis, Inc.
  • Erytech Pharma
  • Synthetic Biologics, Inc.
  • MORE
1. Preface
1.1. Report Description
1.2. Research Methods
1.3. Research Approaches

2. Executive Summary
2.1. Phenylketonuria Treatment Market Highlights
2.2. Phenylketonuria Treatment Market Projection
2.3. Phenylketonuria Treatment Market Regional Highlights

3. Global Phenylketonuria Treatment Market Overview
3.1. Introduction
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
3.3. Porter's Five Forces Analysis
3.4. Growth Matrix Analysis
3.4.1. Growth Matrix Analysis by Product Type
3.4.2. Growth Matrix Analysis by Route of Administration
3.4.3. Growth Matrix Analysis by Distribution Channel
3.4.4. Growth Matrix Analysis by Region
3.5. Value Chain Analysis of Phenylketonuria Treatment Market

4. Phenylketonuria Treatment Market Macro Indicator Analysis

5. Global Phenylketonuria Treatment Market by Product Type
5.1. Dietary Supplement
5.2. Drugs
5.2.1. Biopten
5.2.2. Kuvan
5.2.3. Others

6. Global Phenylketonuria Treatment Market by Route of Administration
6.1. Oral
6.2. Parenteral

7. Global Phenylketonuria Treatment Market by Distribution Channel
7.1. Hospital Pharmacies
7.2. Online Pharmacies
7.3. Pediatric Clinics
7.4. Drug Stores

8. Global Phenylketonuria Treatment Market by Region 2019-2025
8.1. North America
8.1.1. North America Phenylketonuria Treatment Market by Product Type
8.1.2. North America Phenylketonuria Treatment Market by Route of Administration
8.1.3. North America Phenylketonuria Treatment Market by Distribution Channel
8.1.4. North America Phenylketonuria Treatment Market by Country
8.2. Europe
8.2.1. Europe Phenylketonuria Treatment Market by Product Type
8.2.2. Europe Phenylketonuria Treatment Market by Route of Administration
8.2.3. Europe Phenylketonuria Treatment Market by Distribution Channel
8.2.4. Europe Phenylketonuria Treatment Market by Country
8.3. Asia-Pacific
8.3.1. Asia-Pacific Phenylketonuria Treatment Market by Product Type
8.3.2. Asia-Pacific Phenylketonuria Treatment Market by Route of Administration
8.3.3. Asia-Pacific Phenylketonuria Treatment Market by Distribution Channel
8.3.4. Asia-Pacific Phenylketonuria Treatment Market by Country
8.4. RoW
8.4.1. RoW Phenylketonuria Treatment Market by Product Type
8.4.2. RoW Phenylketonuria Treatment Market by Route of Administration
8.4.3. RoW Phenylketonuria Treatment Market by Distribution Channel
8.4.4. RoW Phenylketonuria Treatment Market by Sub-region

9. Company Profiles and Competitive Landscape
9.1. Competitive Landscape in the Global Phenylketonuria Treatment Market
9.2. Companies Profiles
9.2.1. Erytech Pharma
9.2.2. Daiichi Sankyo Company, Limited
9.2.3. SOM Innovation Biotech, S.L.
9.2.4. Codexis, Inc.
9.2.5. Synthetic Biologics, Inc.
9.2.6. American Gene Technologies International Inc
9.2.7. Dimension Therapeutics, Inc
9.2.8. BioMarin Pharmaceutical Inc.
9.2.9. Cambrooke Therapeutics, Inc.
9.2.10. Danone

10. Appendix
10.1. Primary Research Findings and Questionnaire
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • Erytech Pharma
  • Daiichi Sankyo Company, Limited
  • SOM Innovation Biotech, S.L.
  • Codexis, Inc.
  • Synthetic Biologics, Inc.
  • American Gene Technologies International Inc
  • Dimension Therapeutics, Inc
  • BioMarin Pharmaceutical Inc.
  • Cambrooke T
Note: Product cover images may vary from those shown
Adroll
adroll